表紙:世界の眼科手術装置および治療薬市場:世界業界分析、規模、シェア、成長、動向、予測
市場調査レポート
商品コード
812813

世界の眼科手術装置および治療薬市場:世界業界分析、規模、シェア、成長、動向、予測

Ophthalmic Surgical Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

出版日: | 発行: Transparency Market Research | ページ情報: 英文 220 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.03円
世界の眼科手術装置および治療薬市場:世界業界分析、規模、シェア、成長、動向、予測
出版日: 2019年02月19日
発行: Transparency Market Research
ページ情報: 英文 220 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の眼科手術装置および治療薬市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 序論

第2章 仮定と調査方法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
  • 市場分析と予測

第5章 市場見通し

  • パイプライン分析
  • 技術進歩
  • 概要:視力障害につながる眼病と世界の盲目原因分析

第6章 製品別市場分析と予測

  • イントロダクションと定義
  • 主な調査結果と動向
  • 市場価値予測
    • 治療薬
    • 手術装置
    • ビジョンケア
  • 市場の魅力度

第7章 エンドユーザー別市場分析と予測

  • イントロダクションと定義
  • 主な調査結果と動向
  • 市場価値予測
    • 病院
    • 眼科クリニック
    • 外来外科センター
  • 市場の魅力度

第8章 地域別市場分析と予測

  • 主な調査結果
  • 市場価値予測
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力度

第9章 北米

第10章 欧州

第11章 アジア太平洋地域

第12章 ラテンアメリカ

第13章 中東・アフリカ

第14章 競合環境

  • 競合マトリクス
  • 企業プロファイル
    • Allergan plc.
    • Novartis AG
    • Johnson & Johnson Vision Care, Inc.
    • Bayer AG
    • F. Hoffmann-La Roche Ltd.
    • Bausch Health Companies Inc.
    • Regeneron Pharmaceuticals, Inc.
    • Santen Pharmaceutical Co., Ltd.
    • HOYA株式会社
    • Carl Zeiss Meditec AG
図表

List of Tables

  • Table 01: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 02: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016-2026
  • Table 03: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016-2026
  • Table 04: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016-2026
  • Table 05: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, Anti-glaucoma Drugs, 2016-2026
  • Table 06: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016-2026
  • Table 07: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016-2026
  • Table 08: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016-2026
  • Table 09: Global Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 10: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 11: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • Table 12: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 13: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016-2026
  • Table 14: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-inflammatory Drugs, 2016-2026
  • Table 15: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-infective Drugs, 2016-2026
  • Table 16: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics- Anti-glaucoma Drugs, 2016-2026
  • Table 17: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016-2026
  • Table 18: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016-2026
  • Table 19: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016-2026
  • Table 20: North America Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 21: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016-2026
  • Table 22: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 23: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016-2026
  • Table 24: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-inflammatory Drugs, 2016-2026
  • Table 25: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-infective Drugs, 2016-2026
  • Table 26: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics- Anti-glaucoma Drugs, 2016-2026
  • Table 27: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016-2026
  • Table 28: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016-2026
  • Table 29: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016-2026
  • Table 30: Europe Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 31: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 32: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 33: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016-2026
  • Table 34: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016-2026
  • Table 35: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016-2026
  • Table 36: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-glaucoma Drugs, 2016-2026
  • Table 37: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016-2026
  • Table 38: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016-2026
  • Table 39: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016-2026
  • Table 40: Asia Pacific Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 41: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 42: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 43: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016-2026
  • Table 44: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016-2026
  • Table 45: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016-2026
  • Table 46: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-glaucoma Drugs, 2016-2026
  • Table 47: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016-2026
  • Table 48: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016-2026
  • Table 49: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016-2026
  • Table 50: Latin America Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 51: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 52: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 53: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016-2026
  • Table 54: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016-2026
  • Table 55: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016-2026
  • Table 56: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-glaucoma Drugs, 2016-2026
  • Table 57: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016-2026
  • Table 58: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016-2026
  • Table 59: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016-2026
  • Table 60: Middle East & Africa Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016-2026

List of Figures

  • Figure 01: Global Ophthalmic Surgical Devices and Therapeutics Market Snapshot
  • Figure 02: Global Ophthalmic Surgical Devices and Therapeutics Market, by Product Type
  • Figure 03: Global Ophthalmic Surgical Devices and Therapeutics Market Snapshot
  • Figure 04: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type
  • Figure 05: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user
  • Figure 06: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, 2016-2026
  • Figure 07: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type (2017)
  • Figure 08: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user (2017)
  • Figure 09: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Region (2017)
  • Figure 10: Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type, 2018-2026
  • Figure 11: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
  • Figure 12: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection (%), by Therapeutics, 2016-2026
  • Figure 13: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection (%), by Surgical Devices, 2016-2026
  • Figure 14: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection (%), by Vision Care, 2016-2026
  • Figure 15: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
  • Figure 16: Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018-2026
  • Figure 18: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection (%), by Ophthalmic Clinics, 2016-2026
  • Figure 17: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection (%), by Hospitals, 2016-2026
  • Figure 19: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection Ambulatory Surgery Centers, 2016-2026
  • Figure 20: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Region, for 2017 and 2026
  • Figure 21: Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Region, 2018-2026
  • Figure 22: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 23: North America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country, 2018-2026
  • Figure 24: North America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Country, 2017 and 2026
  • Figure 25: North America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type, 2016-2026
  • Figure 26: North America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
  • Figure 27: North America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
  • Figure 28: North America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018-2026
  • Figure 29: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 30: Europe Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country/Sub-Region, 2018-2026
  • Figure 31: Europe Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Country/Sub-Region, 2017 and 2026
  • Figure 32: Europe Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type, 2016-2026
  • Figure 33: Europe Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
  • Figure 34: Europe Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
  • Figure 35: Europe Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018-2026
  • Figure 36: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 37: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 38: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Country/Sub-region, for 2017 and 2026
  • Figure 39: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type, 2016-2026
  • Figure 40: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
  • Figure 41: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
  • Figure 42: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018-2026
  • Figure 43: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 44: Latin America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 45: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 46: Latin America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type, 2016-2026
  • Figure 47: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
  • Figure 48: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
  • Figure 49: Latin America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018-2026
  • Figure 50: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 51: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-Region, 2018-2026
  • Figure 52: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Country/Sub-Region, 2017 and 2026
  • Figure 53: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, By Product Type, 2016-2026
  • Figure 54: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
  • Figure 55: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
  • Figure 56: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018-2026
目次

Title:
Ophthalmic Surgical Devices and Therapeutics (Eye Care) Market (Product Type - Therapeutics, Surgical Devices, Vision Care; End user - Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Ophthalmic Surgical Devices and Therapeutics Market: Overview

This report analyzes the current and future scenario of the global ophthalmic surgical devices and therapeutics market for the period 2018 to 2026. Rise in geriatric population, increased prevalence of ocular disorders, and high unmet medical needs are likely to be major drivers of the global ophthalmic surgical devices and therapeutics market during the forecast period.

The ophthalmic surgical devices and therapeutics market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on product type, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the ophthalmic surgical devices and therapeutics market.

Ophthalmic Surgical Devices and Therapeutics Market: Key Segments

Based on product type, the global ophthalmic surgical devices and therapeutics market has been segmented into therapeutics, surgical devices, and vision care. In terms of end-user, the global ophthalmic surgical devices and therapeutics market has been divided into hospitals, ophthalmic clinics, and ambulatory surgery centers. Market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.

Ophthalmic Surgical Devices and Therapeutics Market: Regional Outlook

In terms of region, the global ophthalmic surgical devices and therapeutics market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report

The report also profiles major players operating in the global ophthalmic surgical devices and therapeutics market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Allergan Plc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Carl Zeiss Meditec AG, HOYA Corporation, and Bayer AG. The global ophthalmic surgical devices and therapeutics market has been segmented as below:

  • Ophthalmic Surgical Devices and Therapeutics Market, by Product Type
  • Therapeutics
  • Anti-inflammatory Drugs
  • NSAIDs
  • Steroids
  • Anti-infective Drugs
  • Anti-fungal Drugs
  • Anti-bacterial Drugs
  • Others
  • Anti-infective Drugs
  • Alpha Agonist
  • Beta Blockers
  • Prostaglandin Analogs
  • Combined Medication
  • Others
  • Anti-allergy Drugs
  • Anti-VEGF Agents
  • Others
  • Surgical Devices
  • Cataract Surgery Devices
  • Intraocular lens (IOL)
  • Ophthalmic Viscoelastic Devices (OVDs)
  • Others
  • Glaucoma Surgery Devices
  • Refractive Surgery Devices
  • Vitreoretinal Surgery Devices
  • Vision Care
  • Contact Lenses
  • Spectacle Lenses
  • Accessories
  • Ophthalmic Surgical Devices and Therapeutics Market, by End-user
  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgery Centers
  • Ophthalmic Surgical Devices and Therapeutics Market, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • South Africa
  • GCC Countries
  • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ophthalmic Surgical Devices and Therapeutics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, 2016-2026
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

  • 5.1. Pipeline Analysis
  • 5.2. Technological Advancements
  • 5.3. Snapshot: Ocular Diseases Leading to Visual Impairment & Analysis of Global Causes of Blindness (%)

6. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016-2026
    • 6.3.1. Therapeutics
      • 6.3.1.1. Anti-inflammatory Drugs
        • 6.3.1.1.1. NSAIDs
        • 6.3.1.1.2. Steroids
      • 6.3.1.2. Anti-infective Drugs
        • 6.3.1.2.1. Anti-fungal Drugs
        • 6.3.1.2.2. Anti-bacterial Drugs
        • 6.3.1.2.3. Others
      • 6.3.1.3. Anti-glaucoma Drugs
        • 6.3.1.3.1. Alpha Agonist
        • 6.3.1.3.2. Beta Blockers
        • 6.3.1.3.3. Prostaglandin Analogs
        • 6.3.1.3.4. Combined Medication
        • 6.3.1.3.5. Others
      • 6.3.1.4. Anti-allergy Drugs
      • 6.3.1.5. Anti-VEGF Agents
      • 6.3.1.6. Others
    • 6.3.2. Surgical Devices
      • 6.3.2.1. Cataract Surgery Devices
        • 6.3.2.1.1. Intraocular lens (IOL)
        • 6.3.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
        • 6.3.2.1.3. Others
      • 6.3.2.2. Glaucoma Surgery Devices
      • 6.3.2.3. Refractive Surgery Devices
      • 6.3.2.4. Vitreoretinal Surgery Devices
    • 6.3.3. Vision Care
      • 6.3.3.1. Contact Lenses
      • 6.3.3.2. Spectacle Lenses
      • 6.3.3.3. Accessories
  • 6.4. Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type

7. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016-2026
    • 7.3.1. Hospitals
    • 7.3.2. Ophthalmic Clinics
    • 7.3.3. Ambulatory Surgery Centers
  • 7.4. Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user

8. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Global Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country/Region

9. North America Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. North America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016-2026
    • 9.2.1. Therapeutics
      • 9.2.1.1. Anti-inflammatory Drugs
        • 9.2.1.1.1. NSAIDs
        • 9.2.1.1.2. Steroids
      • 9.2.1.2. Anti-infective Drugs
        • 9.2.1.2.1. Anti-fungal Drugs
        • 9.2.1.2.2. Anti-bacterial Drugs
        • 9.2.1.2.3. Others
      • 9.2.1.3. Anti-glaucoma Drugs
        • 9.2.1.3.1. Alpha Agonist
        • 9.2.1.3.2. Beta Blockers
        • 9.2.1.3.3. Prostaglandin Analogs
        • 9.2.1.3.4. Combined Medication
        • 9.2.1.3.5. Others
      • 9.2.1.4. Anti-allergy Drugs
      • 9.2.1.5. Anti-VEGF Agents
      • 9.2.1.6. Others
    • 9.2.2. Surgical Devices
      • 9.2.2.1. Cataract Surgery Devices
        • 9.2.2.1.1. Intraocular lens (IOL)
        • 9.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
        • 9.2.2.1.3. Others
      • 9.2.2.2. Glaucoma Surgery Devices
      • 9.2.2.3. Refractive Surgery Devices
      • 9.2.2.4. Vitreoretinal Surgery Devices
    • 9.2.3. Vision Care
      • 9.2.3.1. Contact Lenses
      • 9.2.3.2. Spectacle Lenses
      • 9.2.3.3. Accessories
  • 9.3. North America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016-2026
    • 9.3.1. Hospitals
    • 9.3.2. Ophthalmic Clinics
    • 9.3.3. Ambulatory Surgery Centers
  • 9.4. North America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country, 2016-2026
    • 9.4.1. US
    • 9.4.2. Canada
  • 9.5. North America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
    • 9.5.1. By Product Type
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Europe Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016-2026
    • 10.2.1. Therapeutics
      • 10.2.1.1. Anti-inflammatory Drugs
        • 10.2.1.1.1. NSAIDs
        • 10.2.1.1.2. Steroids
      • 10.2.1.2. Anti-infective Drugs
        • 10.2.1.2.1. Anti-fungal Drugs
        • 10.2.1.2.2. Anti-bacterial Drugs
        • 10.2.1.2.3. Others
      • 10.2.1.3. Anti-glaucoma Drugs
        • 10.2.1.3.1. Alpha Agonist
        • 10.2.1.3.2. Beta Blockers
        • 10.2.1.3.3. Prostaglandin Analogs
        • 10.2.1.3.4. Combined Medication
        • 10.2.1.3.5. Others
      • 10.2.1.4. Anti-allergy Drugs
      • 10.2.1.5. Anti-VEGF Agents
      • 10.2.1.6. Others
    • 10.2.2. Surgical Devices
      • 10.2.2.1. Cataract Surgery Devices
        • 10.2.2.1.1. Intraocular lens (IOL)
        • 10.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
        • 10.2.2.1.3. Others
      • 10.2.2.2. Glaucoma Surgery Devices
      • 10.2.2.3. Refractive Surgery Devices
      • 10.2.2.4. Vitreoretinal Surgery Devices
    • 10.2.3. Vision Care
      • 10.2.3.1. Contact Lenses
      • 10.2.3.2. Spectacle Lenses
      • 10.2.3.3. Accessories
  • 10.3. Europe Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016-2026
    • 10.3.1. Hospitals
    • 10.3.2. Ophthalmic Clinics
    • 10.3.3. Ambulatory Surgery Centers
  • 10.4. Europe Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016-2026
    • 10.4.1. Germany
    • 10.4.2. France
    • 10.4.3. U.K.
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Europe Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
    • 10.5.1. By Product Type
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016-2026
    • 11.2.1. Therapeutics
      • 11.2.1.1. Anti-inflammatory Drugs
        • 11.2.1.1.1. NSAIDs
        • 11.2.1.1.2. Steroids
      • 11.2.1.2. Anti-infective Drugs
        • 11.2.1.2.1. Anti-fungal Drugs
        • 11.2.1.2.2. Anti-bacterial Drugs
        • 11.2.1.2.3. Others
      • 11.2.1.3. Anti-glaucoma Drugs
        • 11.2.1.3.1. Alpha Agonist
        • 11.2.1.3.2. Beta Blockers
        • 11.2.1.3.3. Prostaglandin Analogs
        • 11.2.1.3.4. Combined Medication
        • 11.2.1.3.5. Others
      • 11.2.1.4. Anti-allergy Drugs
      • 11.2.1.5. Anti-VEGF Agents
      • 11.2.1.6. Others
    • 11.2.2. Surgical Devices
      • 11.2.2.1. Cataract Surgery Devices
        • 11.2.2.1.1. Intraocular lens (IOL)
        • 11.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
        • 11.2.2.1.3. Others
      • 11.2.2.2. Glaucoma Surgery Devices
      • 11.2.2.3. Refractive Surgery Devices
      • 11.2.2.4. Vitreoretinal Surgery Devices
    • 11.2.3. Vision Care
      • 11.2.3.1. Contact Lenses
      • 11.2.3.2. Spectacle Lenses
      • 11.2.3.3. Accessories
  • 11.3. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016-2026
    • 11.3.1. Hospitals
    • 11.3.2. Ophthalmic Clinics
    • 11.3.3. Ambulatory Surgery Centers
  • 11.4. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016-2026
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
    • 11.5.1. By Product Type
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016-2026
    • 12.2.1. Therapeutics
      • 12.2.1.1. Anti-inflammatory Drugs
        • 12.2.1.1.1. NSAIDs
        • 12.2.1.1.2. Steroids
      • 12.2.1.2. Anti-infective Drugs
        • 12.2.1.2.1. Anti-fungal Drugs
        • 12.2.1.2.2. Anti-bacterial Drugs
        • 12.2.1.2.3. Others
      • 12.2.1.3. Anti-glaucoma Drugs
        • 12.2.1.3.1. Alpha Agonist
        • 12.2.1.3.2. Beta Blockers
        • 12.2.1.3.3. Prostaglandin Analogs
        • 12.2.1.3.4. Combined Medication
        • 12.2.1.3.5. Others
      • 12.2.1.4. Anti-allergy Drugs
      • 12.2.1.5. Anti-VEGF Agents
      • 12.2.1.6. Others
    • 12.2.2. Surgical Devices
      • 12.2.2.1. Cataract Surgery Devices
        • 12.2.2.1.1. Intraocular lens (IOL)
        • 12.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
        • 12.2.2.1.3. Others
      • 12.2.2.2. Glaucoma Surgery Devices
      • 12.2.2.3. Refractive Surgery Devices
      • 12.2.2.4. Vitreoretinal Surgery Devices
    • 12.2.3. Vision Care
      • 12.2.3.1. Contact Lenses
      • 12.2.3.2. Spectacle Lenses
      • 12.2.3.3. Accessories
  • 12.3. Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016-2026
    • 12.3.1. Hospitals
    • 12.3.2. Ophthalmic Clinics
    • 12.3.3. Ambulatory Surgery Centers
  • 12.4. Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016-2026
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Latin America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
    • 12.5.1. By Product Type
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016-2026
    • 13.2.1. Therapeutics
      • 13.2.1.1. Anti-inflammatory Drugs
        • 13.2.1.1.1. NSAIDs
        • 13.2.1.1.2. Steroids
      • 13.2.1.2. Anti-infective Drugs
        • 13.2.1.2.1. Anti-fungal Drugs
        • 13.2.1.2.2. Anti-bacterial Drugs
        • 13.2.1.2.3. Others
      • 13.2.1.3. Anti-glaucoma Drugs
        • 13.2.1.3.1. Alpha Agonist
        • 13.2.1.3.2. Beta Blockers
        • 13.2.1.3.3. Prostaglandin Analogs
        • 13.2.1.3.4. Combined Medication
        • 13.2.1.3.5. Others
      • 13.2.1.4. Anti-allergy Drugs
      • 13.2.1.5. Anti-VEGF Agents
      • 13.2.1.6. Others
    • 13.2.2. Surgical Devices
      • 13.2.2.1. Cataract Surgery Devices
        • 13.2.2.1.1. Intraocular lens (IOL)
        • 13.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
        • 13.2.2.1.3. Others
      • 13.2.2.2. Glaucoma Surgery Devices
      • 13.2.2.3. Refractive Surgery Devices
      • 13.2.2.4. Vitreoretinal Surgery Devices
    • 13.2.3. Vision Care
      • 13.2.3.1. Contact Lenses
      • 13.2.3.2. Spectacle Lenses
      • 13.2.3.3. Accessories
  • 13.3. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016-2026
    • 13.3.1. Hospitals
    • 13.3.2. Ophthalmic Clinics
    • 13.3.3. Ambulatory Surgery Centers
  • 13.4. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016-2026
    • 13.4.1. GCC Countries
    • 13.4.2. Israel
    • 13.4.3. South Africa
    • 13.4.4. Rest of MEA
  • 13.5. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
    • 13.5.1. By Product Type
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Company Profiles
    • 14.2.1. Allergan plc.
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Financial Overview
      • 14.2.1.5. Strategic Overview
    • 14.2.2. Novartis AG
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Financial Overview
      • 14.2.1.5. Strategic Overview
    • 14.2.3. Johnson & Johnson Vision Care, Inc.
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Financial Overview
      • 14.2.1.5. Strategic Overview
    • 14.2.4. Bayer AG
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Financial Overview
      • 14.2.1.5. Strategic Overview
    • 14.2.5. F. Hoffmann-La Roche Ltd.
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Financial Overview
      • 14.2.1.5. Strategic Overview
    • 14.2.6. Bausch Health Companies Inc.
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Financial Overview
      • 14.2.1.5. Strategic Overview
    • 14.2.7. Regeneron Pharmaceuticals, Inc.
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Financial Overview
      • 14.2.1.5. Strategic Overview
    • 14.2.8. Santen Pharmaceutical Co., Ltd.
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Financial Overview
      • 14.2.1.5. Strategic Overview
    • 14.2.9. HOYA Corporation
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Financial Overview
      • 14.2.1.5. Strategic Overview
    • 14.5.10. Carl Zeiss Meditec AG
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Product Portfolio
      • 14.2.1.3. SWOT Analysis
      • 14.2.1.4. Financial Overview
      • 14.2.1.5. Strategic Overview